Search Ontology:
ChEBI

4-(2-iodacetamido)-TEMPO

Term ID
CHEBI:180674
Synonyms
  • 2,2,6,6-tetramethyl-4-(2-iodoacetamide)piperidine-N-oxyl
  • 2,2,6,6-tetramethyl-4-[2-iodoacetamido]piperidine-1-oxyl
  • 2,2,6,6-tetramethyl-4-iodoacetamide-piperidin-1-N-oxyl
  • 2,2,6,6-tetramethyl-4-iodoacetamido-1-piperidinyloxy
  • 2,2,6,6-tetramethylpiperidine-1-oxyl-4-(iodoacetamide)
  • 4-(2-iodacetamido)-2,2,6,6-tetramethylpiperidine-1-oxyl
  • 4-(2-iodacetamido)-2,2,6,6-tetramethylpiperidinyloxyl
  • 4-(2-iodoacetamido)-2,2,6,6-tetramethyl-1-piperidinooxy
  • 4-(2-iodoacetamido)-2,2,6,6-tetramethyl-1-piperidinooxyl
  • 4-(2-iodoacetamido)-2,2,6,6-tetramethylpiperidine 1-oxyl
  • 4-(2-iodoacetamido)-2,2,6,6-tetramethylpiperidine-1-oxyl
  • 4-(2-iodoacetamido)-2,2,6,6-tetramethylpiperidinooxyl
  • 4-(2-iodoacetamido)-TEMPO free radical
  • 4-(N-iodoacetamide)-2,2,6,6-tetramethylpiperidine-1-oxyl
  • 4-[(2-iodoacetyl)amino]-2,2,6,6-tetramethyl-1-piperidinyloxy
  • [4-(2-iodoacetamido)-2,2,6,6-tetramethylpiperidin-1-yl]oxidanyl
  • IASL
  • N-(1-oxy-2,2,6,6-tetramethyl-4-piperidinyl)iodoacetamide
  • N-(1-oxyl-2,2,6,6-tetramethyl-4-piperidinyl)-2-iodoacetamide
  • N-(1-oxyl-2,2,6,6-tetramethyl-4-piperidinyl)iodoacetamide
  • N-(2,2,6,6-tetramethyl-4-piperidinyl-1-oxy)iodoacetamide
  • N-(oxyl-2,2,6,6-tetramethylpiperid-4-yl)iodoacetamide
  • Synvar 101
(all 23)
Definition
A piperidinecarboxamide that is TEMPO carrying an 2-iodoacetamido group at position 4.
References
(all 16)
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
is a type of
has_functional_parent
has_role
Phenotype
Phenotype resulting from 4-(2-iodacetamido)-TEMPO
No data available
Phenotype where environments contain 4-(2-iodacetamido)-TEMPO
No data available
Phenotype modified by environments containing 4-(2-iodacetamido)-TEMPO
Phenotype affecting 4-(2-iodacetamido)-TEMPO
Human Disease Model
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.